DNA Methylation Profiles in a Polygenic Mouse Model of Diet-Induced Obesity
饮食引起肥胖的多基因小鼠模型中的 DNA 甲基化谱
基本信息
- 批准号:7392255
- 负责人:
- 金额:$ 14.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAdultAgingAnimal ModelApolipoprotein EAppearanceArterial Fatty StreakAtherogenic DietAtherosclerosisBody WeightC57BL/6 MouseCandidate Disease GeneCardiovascular DiseasesCholesterolComplexControl AnimalCoronary heart diseaseCpG dinucleotideDNA MethylationDevelopmentDiabetes MellitusDietDiseaseDrug FormulationsEnvironmental ExposureExposure toFatty acid glycerol estersGene ExpressionGene Expression RegulationGene SilencingGenesGeneticGenomeGoalsHumanHyperinsulinismIn VitroIndividualInsulinInsulin ResistanceLesionLibrariesMethylationMicroarray AnalysisModificationMusMutationNon-Insulin-Dependent Diabetes MellitusNormal RangeNutrientNutrition, OtherObesityOrganPathogenesisPatternPlasmaPopulationPredispositionProcessReportingRiskRisk FactorsRoleSuggestionTestingTissue-Specific Gene ExpressionTissuesTwin Multiple BirthTwin StudiesVariantWeightWeight GainWild Type Mousebasecohortcomparison groupconceptfeedingin vivomouse modelnormal agingnovelpromoterresearch studyresponse
项目摘要
DESCRIPTION (provided by applicant): Obesity is a major risk factor for the development of coronary heart disease (CHD) and non-insulin dependent diabetes mellitus (NIDDM). Although the results of twin studies and adoption studies provide strong support for a genetic influence on body weight, mutations causing obesity are rare in the population and major genes contributing to common obesity have not been identified. This has led to the suggestion that the variation in adiposity between individuals may be determined by multiple genetic loci with variations in any single gene producing only a moderate effect. In accordance with this formulation, obesity has been reported to be associated with differential gene expression, and the composite effect of these alterations may be at least partly responsible for the susceptibility to NIDDM and CHD. It is the long-term goal of this proposal to evaluate whether modifications in DNA methylation patterns that may result in either activation or silencing of genes can be detected when comparing obese and lean individuals. The first step in approaching this long-term goal is a proof-of-concept study using an animal model in an experimental setting. Provision of a high-fat diet to C57BL/6 mice results in increased body weight, hyperinsulinemia and insulin-resistance, and the accelerated appearance of aortic fatty streak lesions when compared to littermates fed normal mouse chow. The use of these mice will allow nutrient exposure to be varied while keeping genetic background constant. Based on previous reports that changes in DNA methylation may precede the development of atherosclerotic lesions in mice with a mutation in the apolipoprotein E gene causing elevated plasma cholesterol, the goal of this proposal is to test the hypotheses that (a) the pathogenesis of adult-onset obesity and atherosclerosis in wild- type mice fed an atherogenic diet may be correlated with functional differences in DNA methylation between treated and control animals and (b) that acquired variability in DNA methylation may be involved in normal aging and could contribute to the development of complex disease by pursuing the following specific aims: 1) to evaluate whether diet-induced obesity and atherosclerosis in C57BL/6 mice entails alterations in DNA methylation patterns in atherosclerotic lesions and other target organs by genome-wide microarray analysis. 2) to identify and clone methylated sequences, and validate that genes with altered methylation patterns detected by microarray analysis are regulated by methylation in vitro and in vivo. 3) to assess global and gene-specific DNA methylation in multiple tissues during aging in C57BL/6 mice. These experiments may reveal the role and sequence of DNA methylation changes in simultaneous disease processes in response to nutrition and other environmental influences, and may also yield a set of novel candidate genes that can later be tested in association studies in human cohorts. Consuming a high-fat diet is an environmental exposure that may alter DNA methylation and change gene expression. This will be studied first in mice to see whether this type of change could help to explain the increased risk for non-insulin dependent diabetes mellitus (NIDDM) and coronary heart disease (CHD) with obesity.
描述(由申请人提供):肥胖是冠心病(CHD)和非胰岛素依赖型糖尿病(NIDDM)发展的主要危险因素。虽然双胞胎研究和收养研究的结果为基因对体重的影响提供了强有力的支持,但导致肥胖的突变在人群中很少见,导致常见肥胖的主要基因尚未确定。这导致了一种观点,即个体之间的肥胖差异可能是由多个基因位点决定的,任何一个基因的变异只会产生适度的影响。根据这一说法,肥胖已被报道与差异基因表达有关,这些改变的综合作用可能至少部分地导致NIDDM和冠心病的易感性。本研究的长期目标是评估在比较肥胖和瘦弱个体时,是否可以检测到可能导致基因激活或沉默的DNA甲基化模式的修饰。实现这一长期目标的第一步是在实验环境中使用动物模型进行概念验证研究。给C57BL/6小鼠提供高脂肪饮食会导致体重增加、高胰岛素血症和胰岛素抵抗,并且与喂食正常小鼠食物的窝鼠相比,主动脉脂肪条纹病变的出现速度加快。使用这些老鼠可以在保持遗传背景不变的情况下,改变营养物质的暴露。根据先前的报道,在载脂蛋白E基因突变导致血浆胆固醇升高的小鼠中,DNA甲基化的变化可能先于动脉粥样硬化病变的发展,本研究的目的是验证以下假设:(a)在喂食致动脉粥样硬化饮食的野生型小鼠中,成年发病的肥胖和动脉粥样硬化的发病机制可能与治疗动物和对照动物之间DNA甲基化的功能差异有关;(b) DNA甲基化的获得性变异可能与正常衰老有关,并可能通过追求以下具体目标来促进复杂疾病的发展:1)通过全基因组微阵列分析,评估C57BL/6小鼠饮食诱导的肥胖和动脉粥样硬化是否与动脉粥样硬化病变和其他靶器官的DNA甲基化模式改变有关。2)鉴定和克隆甲基化序列,验证微阵列分析检测到的甲基化模式改变的基因在体内和体外受到甲基化的调控。3)评估C57BL/6小鼠衰老过程中多个组织的整体和基因特异性DNA甲基化。这些实验可能揭示了DNA甲基化变化在应对营养和其他环境影响的同时疾病过程中的作用和顺序,也可能产生一组新的候选基因,这些基因可以在随后的人类群体关联研究中进行测试。食用高脂肪饮食是一种环境暴露,可能会改变DNA甲基化和基因表达。这将首先在老鼠身上进行研究,看看这种类型的变化是否有助于解释肥胖导致非胰岛素依赖型糖尿病(NIDDM)和冠心病(CHD)风险增加的原因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jan Bressler其他文献
Jan Bressler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jan Bressler', 18)}}的其他基金
Metabolomic Profiles of Depression and Social Isolation in Midlife.
中年抑郁症和社会孤立的代谢组学概况。
- 批准号:
9807468 - 财政年份:2019
- 资助金额:
$ 14.85万 - 项目类别:
DNA Methylation Profiles in a Polygenic Mouse Model of Diet-Induced Obesity
饮食引起肥胖的多基因小鼠模型中的 DNA 甲基化谱
- 批准号:
7240293 - 财政年份:2007
- 资助金额:
$ 14.85万 - 项目类别:
相似海外基金
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 14.85万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 14.85万 - 项目类别:
Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 14.85万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 14.85万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 14.85万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 14.85万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 14.85万 - 项目类别:
Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 14.85万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 14.85万 - 项目类别:
EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 14.85万 - 项目类别:
Standard Grant